Injurious ventilation strategies cause systemic release of IL-6 and MIP-2 in rats in vivo

Clin Physiol Funct Imaging. 2003 Nov;23(6):349-53. doi: 10.1046/j.1475-0961.2003.00518.x.

Abstract

In vivo experiments showed no increased production of tumour necrosis factor (TNF) in response to injurious ventilation strategies in otherwise untreated animals. Because interleukin-6 (IL-6) and macrophage inflammatory protein-2 (MIP-2) are more sensitive markers of ventilation-induced cytokine release, serum and bronchoalveolar lavage (BAL) samples were examined for these mediators. Eighty-five adult rats were randomized to three different ventilation strategies. Rats were ventilated with low pressures and low tidal volumes [13/3; peak inspiratory pressure (PIP)/positive end-expiratory pressure (PEEP) in cmH2O], the second group of rats was ventilated with high pressures and low PEEP resulting in high tidal volumes (32/6), and the third group was ventilated with the same high pressures but without PEEP (32/0). Animals were ventilated either for 90 or 240 min, subsequently serum and BAL were collected for analyses on IL-6 and MIP-2 content. Non-ventilated animals served as healthy controls. Ventilation with 32/0 for 90 or 240 min, led to increased serum IL-6 levels. Serum MIP-2 levels were increased by ventilation with 32/6 (90 min) and 32/0 (240 min). Ventilation under any condition, even at 13/3, resulted in elevated MIP-2 levels in the BAL fluid. Even at normal pressures pulmonary MIP-2 levels were increased, suggesting that ventilation may promote pro-inflammatory responses in healthy subjects.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bronchoalveolar Lavage Fluid / chemistry*
  • Chemokine CXCL2
  • Chemokines, CXC / analysis
  • Chemokines, CXC / blood
  • Intercellular Signaling Peptides and Proteins / analysis
  • Intercellular Signaling Peptides and Proteins / blood
  • Interleukin-6 / analysis*
  • Interleukin-6 / blood
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Respiration, Artificial / adverse effects*
  • Respiratory Distress Syndrome / blood*
  • Respiratory Distress Syndrome / etiology*
  • Respiratory Distress Syndrome / immunology

Substances

  • Chemokine CXCL2
  • Chemokines, CXC
  • Cxcl2 protein, rat
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-6